TGFB1 and systemic sclerosis: In a recent study by Jafarinejad-Farsangi (2019), transfection of miR-29a mimics significantly reduced collagen type I expression levels in SSc and TGF-β-stimulated fibroblasts, further supporting the antifibrotic role of miR-29a [58].